Diabetic ketoacidosis with olanzapine treatment [6]

Diabetes Care

Volumn 22, Issue 6, 1999, Pages 1002-1003

  Gatta, Blandine ^a   Rigalleau, Vincent ^a   Gin, Henri ^a  

^a Groupe Hospitalier Sud CHU de Bordeaux   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CLOZAPINE; GLUCAGON; HEMOGLOBIN A1C; INSULIN; KETONE; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; CASE REPORT; DIABETIC KETOACIDOSIS; HEMATOLOGIC DISEASE; HUMAN; HYPERGLYCEMIA; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MALE; SCHIZOPHRENIA; SEIZURE; SIDE EFFECT; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; C-PEPTIDE; DIABETIC KETOACIDOSIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PIRENZEPINE;

EID: 0033047298     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.6.1002     Document Type: Letter

References (3)

1. Colli A, Cocciolo M, Francobandiera G, Rogantin F, Cattalini N: Diabetic ketoacidosis with clozapine treatment (Letter). Diabetes Care 22:176-177, 1999
2. Poll AP, Konicki PE, Jurus GJ, Fuller MA, Jaskiw GE: Clozapine and associated diabetes mellitus. J Clin Psychiatry 58: 108-111, 1997
3. Beasley CM, Tollefson GD, Tran PV: Safety of olanzapine. J Clin Psychiatry 58:13-17, 1997